PROSTATE

PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells

Consequences of interleukin 1β‐triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4+ infiltration mimics human proliferative inflammatory atrophy

Omega‐3 fatty acids decrease prostate cancer progression associated with an anti‐tumor immune response in eugonadal and castrated mice

An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling

Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration‐resistant prostate cancer cells to enzalutamide

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy

Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients

CUL4B/miR‐33b/C‐MYC axis promotes prostate cancer progression

Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer

Comparison of preoperative locoregional Ga‐68 PSMA‐11 PET‐CT and mp‐MRI results with postoperative histopathology of prostate cancer

Clinical effectiveness of docetaxel for castration‐sensitive prostate cancer in a real‐world population‐based analysis

The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells

Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values

Circulating microRNAs in plasma among men with low‐grade and high‐grade prostate cancer at prostate biopsy

Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial)

Trichomonas vaginalis infection and prostate‐specific antigen concentration: Insights into prostate involvement and prostate disease risk

Identification of targets for prostate cancer immunotherapy

Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8 + T cells in benign prostatic hyperplasia

Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion

The metastasis suppressor CD82/KAI1 represses the TGF‐β\n1 and Wnt signalings inducing epithelial‐to‐mesenchymal transition linked to invasiveness of prostate cancer cells

Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22‐gene genomic classifier

PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens

Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole‐mount radical prostatectomy tissue

Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models

Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy

HOXA10 expression profiling in prostate cancer

Circulating inflammation markers and prostate cancer

Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases

Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer

Characterization of glycine‐N‐acyltransferase like 1 (GLYATL1) in prostate cancer

The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center

Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?

DHX15 is up‐regulated in castration‐resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations

Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting

A folic acid‐enriched diet attenuates prostate involution in response to androgen deprivation

TRPV1 in experimental autoimmune prostatitis

Grade groups at diagnosis in African Caribbean men with prostate cancer: Results of a comparative study

Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression

A novel androgen receptor antagonist JJ‐450 inhibits enzalutamide‐resistant mutant ARF876L nuclear import and function

Germline BLM mutations and metastatic prostate cancer

Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)‐3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A

RNA‐based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP‐2 upregulation for a subsequent prostate cancer diagnosis

Optimizing live‐animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID‐NSG mice

Protein kinase D1 induces G1‐phase cell‐cycle arrest independent of Checkpoint kinases by phosphorylating Cell Division Cycle Phosphatase 25

No survival benefit found after extended treatment with docetaxel for patients with castration‐resistant prostate cancer

Tyrosine kinase inhibitor therapy prescribed for non‐urologic diseases can modify PSA titers in urology patients